Friedemann Paul

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).

[Current immunotherapy of multiple sclerosis].

Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.

Power estimation for non-standardized multisite studies.

Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.

What is the future of proof of concept studies in multiple sclerosis?

Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings.

Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.

[Optical coherence tomography in neuromyelitis optica spectrum disorders].

What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).

Magnetic resonance imaging findings at the first episode of acute optic neuritis.

MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.

Venoplasty in MS: Therapeutic intervention without any evidence.

Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).